Mike Scott

8.5k citations

47 papers · 6.2k · 3 hit papers · h-index 24

Impact in

Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Hematology top 0.2%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments

Papers in

Genetics 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 11
- Chronic Lymphocytic Leukemia Research 9
Molecular Biology 18
- Kruppel-like factors research 3

Co-authors: Anthony R. Green (10 shared papers)Linda M. Scott (5 shared papers)Wendy N. Erber (13 shared papers)Peter J. Campbell (4 shared papers)Anthony J. Bench (12 shared papers)George S. Vassiliou (7 shared papers)Elaine Boyd (6 shared papers)Clare East (3 shared papers)
Journals: British Journal of Haematology (8 papers)Blood (5 papers)BMJ (2 papers)The Lancet (2 papers)Leukemia (2 papers)
Partner nations: United Kingdom United States Australia

In The Last Decade

Mike Scott

47 papers receiving 6.0k citations

Mike Scott's Hit Papers

align trajectories log scale

Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis 2015 · 376 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2015 Cell Reports
2007 New England Journal of Medicine
2005 The Lancet

Peers

Countries citing papers authored by Mike Scott

Since Specialization

Citations

This map shows the geographic impact of Mike Scott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mike Scott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mike Scott more than expected).

Fields of papers citing papers by Mike Scott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mike Scott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mike Scott. The network helps show where Mike Scott may publish in the future.

Co-authors

The 25 scholars most cited alongside Mike Scott, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Mike Scott Line = papers co-authored together Mike Scott links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 47 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders The Lancet ·E. Joanna Baxter, Linda M. Scott, Peter J. Campbell, Clare East, Nasios Fourouclas, S Swanton, George S. Vassiliou, Anthony J. Bench, Elaine Boyd, Natasha Joan Curtin, Mike Scott, Wendy N. Erber, Anthony R. Green Hit paper breakdown →	2005	2663
2	JAK2 Exon 12 Mutations in Polycythemia Vera and Idiopathic Erythrocytosis New England Journal of Medicine ·Linda M. Scott, Wei Tong, Ross L. Levine, Mike Scott, Philip Beer, Michael R. Stratton, P. Andrew Futreal, Wendy N. Erber, Mary Frances McMullin, Claire Harrison, Alan J. Warren, D. Gary Gilliland, Harvey F. Lodish, Anthony R. Green Hit paper breakdown →	2007	951
3	Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective study The Lancet ·Peter J. Campbell, Linda M. Scott, Georgina Buck, Keith Wheatley, Clare East, Joanne Marsden, Audrey M. Duffy, Elaine Boyd, Anthony J. Bench, Mike Scott, George S. Vassiliou, Donald Milligan, Steve Smith, Wendy N. Erber, D. Bareford, Bridget S. Wilkins, John T. Reilly, Claire Harrison, Anthony R. Green	2005	489
4	Leukemia-Associated Somatic Mutations Drive Distinct Patterns of Age-Related Clonal Hemopoiesis Cell Reports ·Thomas McKerrell, Naomi Park, Thaidy Moreno-Rodriguez, Carolyn Grove, Hannes Ponstingl, Jonathan Stephens, Charles Crawley, Jenny I. O. Craig, Mike Scott, Clare Hodkinson, E. Joanna Baxter, Roland Rad, Duncan R. Forsyth, Michael A. Quail, Eleftheria Zeggini, Willem H. Ouwehand, Ignacio Varela, George S. Vassiliou Hit paper breakdown →	2015	376
5	Maternal Drinking During Pregnancy: Attention and Short‐Term Memory in 14‐Year‐Old Offspring—A Longitudinal Prospective Study Alcoholism Clinical and Experimental Research ·Ann P. Streissguth, Paul D. Sampson, Heather Carmichael Olson, Fred L. Bookstein, Helen M. Barr, Mike Scott, Julie Feldman, Allan F. Mirsky	1994	325
6	Progenitors homozygous for the V617F mutation occur in most patients with polycythemia vera, but not essential thrombocythemia Blood ·Linda M. Scott, Mike Scott, Peter J. Campbell, Anthony R. Green	2006	220
7	The POM Monoclonals: A Comprehensive Set of Antibodies to Non-Overlapping Prion Protein Epitopes PLoS ONE ·Magdalini Polymenidou, Rita Moos, Mike Scott, Christina J. Sigurdson, Yongzhong Shi, Bill Yajima, Iva Hafner‐Bratkovič, Roman Jerala, Simone Hornemann, Kurt Wüthrich, Anne Bellon, Martin Vey, Graciela Garen, Michael N.G. James, Nat N. V. Kav, Adriano Aguzzi	2008	148
8	A practical strategy for the routine use of BIOMED‐2 PCR assays for detection of B‐ and T‐cell clonality in diagnostic haematopathology British Journal of Haematology ·Hongxiang Liu, Anthony J. Bench, Chris M. Bacon, Karen Payne, Yuanxue Huang, Mike Scott, Wendy N. Erber, John W. Grant, Ming‐Qing Du	2007	102
9	Clinical utility of routine MPL exon 10 analysis in the diagnosis of essential thrombocythaemia and primary myelofibrosis British Journal of Haematology ·Elaine Boyd, Anthony J. Bench, Andrea Goday‐Fernández, Shubha Anand, Krishna J. Vaghela, Philip Beer, Mike Scott, D. Bareford, Anthony R. Green, Brian J.P. Huntly, Wendy N. Erber	2010	88
10	Mobilization of MHC class I molecules from late endosomes to the cell surface following activation of CD34-derived human Langerhans cells Proceedings of the National Academy of Sciences ·Paul A. MacAry, Margaret Lindsay, Mike Scott, Jenny I. O. Craig, J. Paul Luzio, Paul J. Lehner	2001	73
11	Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCRexpression, elevated BCR-ABL levels, or karyotypic instability Blood ·Brian J.P. Huntly, Anthony J. Bench, Éric Delabesse, Alistair Reid, Juan Li, Mike Scott, Lynda J. Campbell, Jenny Byrne, Eleanor M. Pinto, André Brizard, Deitger Niedermeiser, Elizabeth Nacheva, François Guilhot, Michael W. Deininger, Anthony R. Green	2002	68
12	Phospho‐STAT5 and phospho‐Akt expression in chronic myeloproliferative neoplasms British Journal of Haematology ·Lizz Grimwade, Lisa Happerfield, Colin Tristram, Gary McIntosh, Mark Rees, Anthony J. Bench, Elaine Boyd, Marie C Hall, Amy Quinn, Nigel H. Piggott, Paul Scorer, Mike Scott, Wendy N. Erber	2009	58
13	High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies British Journal of Haematology ·Elaine Boyd, Anthony J. Bench, Mars B. van ’t Veer, Penny Wright, David Bloxham, George Follows, Mike Scott	2011	57
14	Synthesis of osteoprotegerin and RANKL by megakaryocytes is modulated by oestrogen British Journal of Haematology ·S Bord, Emma Frith, D.C. Ireland, Mike Scott, J Craig, Juliet Compston	2004	51
15	Osteoclastogenesis during Infective Exacerbations in Patients with Cystic Fibrosis American Journal of Respiratory and Critical Care Medicine ·Elizabeth F. Shead, Charles Haworth, (unknown), Diana Bilton, Mike Scott, Juliet Compston	2006	46
16	AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disorders British Journal of Haematology ·Mark A. Dawson, Jayne Curry, Kelly Barber, Philip Beer, Brent Graham, John F. Lyons, Caroline J. Richardson, Mike Scott, Tomoko Smyth, Matthew Squires, Neil T. Thompson, Anthony R. Green, Nicola G. Wallis	2010	43
17	Differential antiproliferative mechanisms of novel derivative of benzimidazo[1,2- α ]quinoline in colon cancer cells depending on their p53 status Molecular Cancer Therapeutics ·Mirela Sedić, Miroslav Poznić, Peter Gehrig, Mike Scott, Ralph Schlapbach, Marijana Hranjec, Grace Karminski‐Zamola, Krešimir Pavelić, Sandra Kraljević Pavelić	2008	39
18	Postnatal Astrocytes Promote Neural Induction from Adult Human Bone Marrow–Derived Stem Cells Journal of Hematotherapy & Stem Cell Research ·Alexis Joannides, Phil Gaughwin, Mike Scott, Suzanne M. Watt, Alastair Compston, Siddharthan Chandran	2003	35
19	Characterization of antibody–antigen interactions: Comparison between surface plasmon resonance measurements and high-mass matrix-assisted laser desorption/ionization mass spectrometry Analytical Biochemistry ·Claudia Bich, Mike Scott, Andreas Panagiotidis, Ryan J. Wenzel, Alexis Nazabal, Renato Zenobi	2007	34
20	Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sites Genome Research ·George Follows, Pawan Dhami, Berthold Göttgens, Alexander W. Bruce, Peter J. Campbell, Shane C. Dillon, Aileen M. Smith, Christof Koch, Ian J. Donaldson, Mike Scott, Ian Dunham, Mary E. Janes, David Vetrie, Anthony R. Green	2006	32

About Mike Scott

Mike Scott is a scholar working on Genetics, Molecular Biology, Hematology, Immunology and Pathology and Forensic Medicine, having authored 47 papers that have together received 6.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (12 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (11 papers), Chronic Myeloid Leukemia Treatments (9 papers), Chronic Lymphocytic Leukemia Research (9 papers), Lymphoma Diagnosis and Treatment (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Acute Lymphoblastic Leukemia research (5 papers) and Kruppel-like factors research (3 papers). The work is most often cited by research in Genetics (4.4k citations), Hematology (2.8k citations), Rheumatology (1.5k citations), Molecular Biology (2.7k citations) and Oncology (693 citations). Mike Scott has collaborated with scholars based in United Kingdom, United States and Australia. Frequent co-authors include Anthony R. Green, Linda M. Scott, Wendy N. Erber, Peter J. Campbell, Anthony J. Bench, George S. Vassiliou, Elaine Boyd, Clare East, E. Joanna Baxter and Nasios Fourouclas. Their work appears in journals such as British Journal of Haematology, Blood, BMJ, The Lancet and Leukemia.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Mike Scott

Impact in

Papers in i

In The Last Decade

Mike Scott

Mike Scott's Hit Papers

Peers

Countries citing papers authored by Mike Scott

Fields of papers citing papers by Mike Scott

All Works

About Mike Scott

Explore authors with similar magnitude of impact

Papers in